Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab informa… Read more
Rapid Micro Biosystems Inc (RPID) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.204x
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) has a cash flow conversion efficiency ratio of -0.204x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.05 Million) by net assets ($44.33 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Rapid Micro Biosystems Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Rapid Micro Biosystems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Rapid Micro Biosystems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Micro Biosystems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grong Sparebank
OL:GRONG
|
N/A |
|
Uwharrie Capital Corp
OTCQX:UWHR
|
0.004x |
|
AJ Networks Co Ltd
KO:095570
|
0.027x |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IS:TEZOL
|
-0.058x |
|
Investigator Resources Limited
F:VOP
|
-0.012x |
|
Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust
BK:AMATAR
|
0.017x |
|
Aura Energy Limited
PINK:AUEEF
|
-0.108x |
|
Long Hau Corp
VN:LHG
|
N/A |
Annual Cash Flow Conversion Efficiency for Rapid Micro Biosystems Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Rapid Micro Biosystems Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $75.35 Million | $-44.15 Million | -0.586x | -53.36% |
| 2023-12-31 | $117.99 Million | $-45.08 Million | -0.382x | -7.14% |
| 2022-12-31 | $164.17 Million | $-58.55 Million | -0.357x | -43.38% |
| 2021-12-31 | $220.98 Million | $-54.96 Million | -0.249x | +80.08% |
| 2020-12-31 | $24.82 Million | $-31.00 Million | -1.249x | -104.28% |
| 2019-12-31 | $-725.00K | $-21.15 Million | 29.168x | -- |